These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Infection prevention and control practices related to Clostridium difficile infection in Canadian acute and long-term care institutions. Wilkinson K, Gravel D, Taylor G, McGeer A, Simor A, Suh K, Moore D, Kelly S, Boyd D, Mulvey M, Mounchili A, Miller M, Canadian Nosocomial Infection Surveillance Program. Am J Infect Control; 2011 Apr; 39(3):177-82. PubMed ID: 21458680 [Abstract] [Full Text] [Related]
7. Designing a protocol that eliminates Clostridium difficile: a collaborative venture. Whitaker J, Brown BS, Vidal S, Calcaterra M. Am J Infect Control; 2007 Jun; 35(5):310-4. PubMed ID: 17577477 [Abstract] [Full Text] [Related]
18. Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system. McFarland LV, Clarridge JE, Beneda HW, Raugi GJ. Clin Infect Dis; 2007 Nov 01; 45(9):1141-51. PubMed ID: 17918075 [Abstract] [Full Text] [Related]
19. Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2005 Dec 02; 54(47):1201-5. PubMed ID: 16319813 [Abstract] [Full Text] [Related]
20. CE offering--introductory offer Clostridium difficile associated disease (CDAD). Segal P. Pa Nurse; 2007 Jun 02; 62(2):18-9, 21; quiz 21-2. PubMed ID: 17668836 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]